Amiloidózis: vizsgálatok itt: Izrael
8 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleMAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Where
- Haifa, Jerusalem, Tel HaShomer
- Életkor
- 18 év to 90 év
- People
- 1200 worldwide
- Run by
- Intellia Therapeutics
See details and how to joinNCT06128629 · EU 2023-507220-23-00 - 2. fázisTaking peopleStudy of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis
- Where
- Jerusalem
- Életkor
- 18 év and over
- People
- 180
- Run by
- Polina Stepensky
See details and how to joinNCT06971380 - 3. fázisTaking peopleTRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Where
- Be’er Ya‘aqov, Haifa, Jerusalem, Petah Tikva
- Életkor
- 18 év to 85 év
- People
- 1750 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07052903 · EU 2024-519917-72-00 - 1. fázisNot yet taking people in IzraelPhase 1a/b Study of GPRC5D CART Therapy in Relapsed/Refractory Multiple Myeloma and Light-chain Amyloidosis
- Where
- Jerusalem
- Életkor
- 18 év and over
- People
- 160
- Run by
- Hadassah Medical Organization
See details and how to joinNCT07874334 - No phaseTaking peopleConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- Where
- Jerusalem, Ramat Gan
- People
- 1500 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT04561518 - 1. fázisTaking peopleA Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
- Where
- Haifa, Jerusalem, Ramat Gan, Tel Aviv
- Életkor
- 18 év and over
- People
- 276 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06768489 · EU 2024-515316-44-00 - 3. fázisNot yet taking people in IzraelAn Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
- Where
- Beer Yaakov, Haifa, Jerusalem, Rehovot
- People
- 1180 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07789483 · EU 2026-526755-57-00 - 3. fázisCsak meghívásosAn Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
- Where
- Haifa, Jerusalem, Rehovot
- Életkor
- 18 év and over
- People
- 1400 worldwide
- Run by
- Ionis Pharmaceuticals, Inc.
See details and how to joinNCT05667493